Published in Pharmacoeconomics on August 01, 1992
Acamprosate in the treatment of alcoholism: a budget impact analysis for the National Health Service in Italy. Subst Abuse Rehabil (2012) 0.76
Is AIDS a disease of poverty? AIDS Care (1996) 1.53
Economic cost of asthma substantial in NSW. Pharmacoeconomics (1992) 1.39
The effectiveness of domiciliary health visiting: a systematic review of international studies and a selective review of the British literature. Health Technol Assess (2000) 1.15
The cost of HIV treatment and care. A global review. Pharmacoeconomics (2001) 1.09
HIV Guidelines for HIV. Cost of compulsory HIV testing. BMJ (1993) 0.92
Cost-utility analysis of deferasirox compared to standard therapy with desferrioxamine for patients requiring iron chelation therapy in the United Kingdom. Curr Med Res Opin (2008) 0.91
A nurse-delivered advice intervention can reduce chronic non-steroidal anti-inflammatory drug use in general practice: a randomized controlled trial. Rheumatology (Oxford) (2002) 0.91
The use and cost of HIV service provision in England in 1996. National Prospective Monitoring System (NPMS) Steering Group and NPMS Working Party on Costs. Pharmacoeconomics (1998) 0.86
An economic evaluation of home-care assistance for AIDS patients: a pilot study in a town in northern Italy. AIDS (1992) 0.84
Treatment for life for severe haemophilia A- A cost-utility model for prophylaxis vs. on-demand treatment. Haemophilia (2013) 0.84
The influence of socioeconomic status on health service utilisation by patients with AIDS in north Italy. The North-East Italian Group for Planning of AIDS Health Care. Soc Sci Med (1997) 0.84
Hospital care for persons with AIDS in the European Union. Health Policy (1997) 0.82
Pathological findings in harbour porpoises (Phocoena phocoena) from Norwegian and Icelandic waters. J Comp Pathol (2006) 0.82
Reducing the burden of coronary heart disease: health promotion, its effectiveness and cost. Health Educ Res (1996) 0.81
Economic impact of the AIDS epidemic in the European Community: towards multinational scenarios on hospital care and costs. AIDS (1993) 0.80
The economic burden of glaucoma in the UK. The need for a far-sighted policy. Pharmacoeconomics (1995) 0.80
Meta-analysis using individual patient data: efficacy and durability of topical alicaforsen for the treatment of active ulcerative colitis. Aliment Pharmacol Ther (2013) 0.80
Cost analysis of autologous blood transfusion, using cell salvage, compared with allogeneic blood transfusion. Transfus Med (1997) 0.80
AIDS scenarios for The Netherlands; the economic impact on hospitals. Health Policy (1995) 0.79
Phenotypic and genetic divergence among harbour porpoise populations associated with habitat regions in the North Sea and adjacent seas. J Evol Biol (2012) 0.77
Varying efficacy of Helicobacter pylori eradication regimens: cost effectiveness study using a decision analysis model. BMJ (1998) 0.76
Continued inadequacies in data sources for the evaluation of cancer services. Br J Cancer (1997) 0.75
Continued utilization and costs of proton pump inhibitors after Helicobacter pylori eradication in chronic users of gastrointestinal drugs. Aliment Pharmacol Ther (2002) 0.75
Evaluation of Communication Aid Centres in England and Wales. Health Trends (1993) 0.75
Screen test. Health Serv J (1993) 0.75
How do communication aid centres provide services to their clients? Eur J Disord Commun (1993) 0.75
Hospital care for persons with AIDS in European-Union countries; a cross-country comparison. Health Care Manag Sci (2000) 0.75
The application of cost effectiveness analysis to derive a formulary for urinary tract infections. J Chemother (2002) 0.75
Nurses work. No students--no future. Nurs Stand (1993) 0.75
Financing HIV service provision in England: estimated impact of the cost of antiretroviral combination therapy. Int J STD AIDS (1998) 0.75
Extending nurses' professional roles. Nurs Stand (1995) 0.75
Xena, warrior princess, or Judith, sexual warrior? The search for a liberating image of women's power in popular culture. Hist Educ Q (1999) 0.75